Cell Therapy using MSC Market Size, Share and Trends Analysis by Region, Indication (Osteoarthritis, Cardiovascular Disease, Inflammatory and Immunological Disease, Liver Diseases, Cancer, Others) and Segment Forecast, 2022-2027

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$13000

This market intelligence report offers a thorough, forward-looking analysis of the cell therapy using MSC market, and key product and platform stack in a concise format to help executives build proactive and profitable growth strategies.

Note:

* This is an “on-demand” report and will be delivered within 60 business days (excluding weekends and holidays) of the purchase.

* Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

Overview of cell therapy using MSC includes classification by the Indication and region

Cell therapy using MSC market outlook: Analysis as well as historical figures and forecasts of revenue opportunities from the indication and geographic segments.

Cell therapy using MSC market outlook: Analysis as well as forecasts of revenue opportunities from the key Indication segments.

The competitive landscape: An examination of the positioning of leading players in the cell therapy using MSC market.

Key Highlights

The cell therapy using MSC market size was valued at US$ XX billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of XX% during the forecast period (2022-2027). Major factors such as introduction of innovative therapies, increasing fundings & investments, and growing prevalence of chronic diseases, are expected to boost market growth during the forecast period.

Reasons to Buy

This market intelligence report offers a thorough, forward-looking analysis of the cell therapy using MSC market and key opportunities in a concise format to help executives build proactive and profitable growth strategies.

Accompanying GlobalData’s forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in cell therapy using MSC markets.

The report also highlights indication segments.

With different charts and tables, the report is designed for an executive-level audience, boasting presentation quality.

The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from market players, which enables executives to quickly get up to speed with the current and emerging trends in cell therapy using MSC market.

Takeda Pharmaceutical Company
Nipro Corporation
JCR Pharmaceuticals Co.
Ltd
Mesoblast Ltd.
Corestem Inc.
Anterogen Co. Ltd.
Pharmicell Co. Ltd.
Medipost Co. Ltd.

Table of Contents

CHAPTER 01 Executive Summary

1.1 Cell therapy using MSC Market Snapshot

Fig.1 Market Snapshot ($Mn)

1.2 Cell therapy using MSC Market- Key Findings

Fig.2 Key Segment Performance Snapshot

CHAPTER 02 Research Scope and Segmentation

CHAPTER 03 Technology Briefing

3.1 What is Cell therapy using MSC?

CHAPTER 04 Cell therapy using MSC Industry Trends Analysis

4.1 Cell therapy using MSC Market Structure – PORTER’s Analysis

Fig.3 Cell therapy using MSC PORTER’s Five Force Analysis

CHAPTER 05 Exosomes in Therapy Insights

CHAPTER 06 Cell therapy using MSC Revenue Opportunity

6.1 Cell therapy using MSC Market

Fig.4 Cell therapy using MSC Market – Revenue Opportunity Forecast, 2020-2027 ($Mn)

6.2 COVID-19 Impact

CHAPTER 07 Product Approvals/Launches

CHAPTER 08 Cell therapy using MSC Indication Outlook

8.1 Cell therapy using MSC – Indication Deep Dive

Fig.5 Cell therapy using MSC by Indication – Market Overview ($Mn)

Fig.6 Cell therapy using MSC by Indication Share – 2021 & 2027 (%)

8.1.1 Osteoarthritis

Fig.7 Osteoarthritis Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

8.1.2 Cardiovascular Disease

Fig.8 Cardiovascular Disease Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

8.1.3 Inflammatory and Immunological Disease

Fig.9 Inflammatory and Immunological Disease Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

8.1.3 Liver Diseases

Fig.10 Liver Diseases Disease Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

8.1.3 Cancer

Fig.11 Cancer Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

8.1.3 Others

Fig.12 Others Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

CHAPTER 09 Cell therapy using MSC Regional Outlook

9.1 Cell therapy using MSC – Regional Deep Dive

Fig.13 Cell therapy using MSC by Region– Market Overview ($Mn)

Fig.14 Cell therapy using MSC by Region Share – 2021 & 2027 (%)

9.1.1 US

Fig.15 US Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

9.1.2 China

Fig.16 China Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

9.1.3 Japan

Fig.17 Japan Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

CHAPTER 10 Trends, Drivers, and Challenges

10.1 Cell therapy using MSC – Market Trends

10.2 Cell therapy using MSC – Market Drivers

10.3 Cell therapy using MSC – Market Challenges

CHAPTER 011 Cell therapy using MSC Competitive Landscape

11.1 Cell therapy using MSC Competitive Landscape

11.1.1 Takeda Pharmaceutical Company

11.1.2 Nipro Corporation

11.1.3 JCR Pharmaceuticals Co., Ltd

11.1.4 Mesoblast Ltd.

11.1.5 Corestem Inc.

11.1.6 Anterogen Co. Ltd.

11.1.7 Pharmicell Co. Ltd.

11.1.8 Medipost Co. Ltd.

11.2 Cell therapy using MSC Vendor Snapshot

11.2.1 COMPANY SNAPSHOT: Takeda Pharmaceutical Company

11.2.2 COMPANY SNAPSHOT: Nipro Corporation

11.2.3 COMPANY SNAPSHOT: JCR Pharmaceuticals Co., Ltd

11.2.4 COMPANY SNAPSHOT: Daiichi Sankyo Co. Ltd.

11.2.5 COMPANY SNAPSHOT: Corestem Inc.

11.2.6 COMPANY SNAPSHOT: Anterogen Co. Ltd.

11.2.7 COMPANY SNAPSHOT: Pharmicell Co. Ltd.

11.2.8 COMPANY SNAPSHOT: Medipost Co. Ltd.

CHAPTER 012 Appendix

12.1 Methodology

12.2 Key Themes Impacting the Industry

12.3 About US

Contact Us

Table

Table 1 Key Trends Overview

Table 2 Research scope and segmentation

Table 3 Pipeline Products

Table 4 Cell therapy using MSC Market

Table 5 Cell therapy using MSC by Indication, 2020-2027 ($Mn)

Table 6 Cell therapy using MSC by Region, 2020-2027 ($Mn)

Table 7 North America Cell therapy using MSC by Country, 2020-2027 ($Mn)

Table 8 Europe Cell therapy using MSC by Country, 2020-2027 ($Mn)

Table 9 Asia-Pacific Cell therapy using MSC by Country, 2020-2027 ($Mn)

Table 10 Asia-Pacific Cell therapy using MSC by Country, 2020-2027 ($Mn)

Table 11 Takeda Pharmaceutical Company Leading Products

Table 12 Nipro Corporation Leading Products

Table 13 JCR Pharmaceuticals Co., Ltd Leading Products

Table 14 Mesoblast Ltd. Leading Products

Table 15 Corestem Inc. Leading Products

Table 16 Anterogen Co. Ltd. Leading Products

Table 17 Pharmicell Co. Ltd. Leading Products

Table 18 Medipost Co. Ltd. Leading Products

Figures

Fig.1 Market Snapshot ($Mn)

Fig.2 Key Segment Performance Snapshot

Fig.3 Cell therapy using MSC PORTER’s Five Force Analysis

Fig.4 Cell therapy using MSC Market – Revenue Opportunity Forecast, 2020-2027 ($Mn)

Fig.5 Cell therapy using MSC by Indication – Market Overview ($Mn)

Fig.6 Cell therapy using MSC by Indication Share – 2021 & 2027 (%)

Fig.7 Osteoarthritis Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

Fig.8 Cardiovascular Disease Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

Fig.9 Inflammatory and Immunological Disease Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

Fig.10 Liver Diseases Disease Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

Fig.11 Cancer Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

Fig.12 Others Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

Fig.13 Cell therapy using MSC by Region– Market Overview ($Mn)

Fig.14 Cell therapy using MSC by Region Share – 2021 & 2027 (%)

Fig.15 US Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

Fig.16 China Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

Fig.17 Japan Market Revenue Opportunity Forecast, 2020-2027 ($Mn)

Frequently asked questions

Cell Therapy using MSC Market Size, Share and Trends Analysis by Region, Indication (Osteoarthritis, Cardiovascular Disease, Inflammatory and Immunological Disease, Liver Diseases, Cancer, Others) and Segment Forecast, 2022-2027 standard reports
Currency USD
$13,000

Can be used by individual purchaser only

$39,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Cell Therapy using MSC Market Size, Share and Trends Analysis by Region, Indication (Osteoarthritis, Cardiovascular Disease, Inflammatory and Immunological Disease, Liver Diseases, Cancer, Others) and Segment Forecast, 2022-2027 in real time.

  • Access a live Cell Therapy using MSC Market Size, Share and Trends Analysis by Region, Indication (Osteoarthritis, Cardiovascular Disease, Inflammatory and Immunological Disease, Liver Diseases, Cancer, Others) and Segment Forecast, 2022-2027 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.